Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease

Find Full text
Thumbnail
Fulltext:
241975.pdf
Embargo:
until further notice
Size:
2.394Mb
Format:
PDF
Description:
Publisher’s version
Publication year
2021
Author(s)
Mahmmod, Shaden
Schultheiss, Johannes P.D.
Bodegraven, Adriaan A. van
Dijkstra, Gerard
Gilissen, Lennard P. L.
Hoentjen, F.
Smits, Lisa J.T.
Oldenburg, Bas
Fidder, Herma H.
Source
Inflammatory Bowel Diseases, 27, 12, (2021), pp. 1954-1962
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/241975   https://hdl.handle.net/2066/241975
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.